Effects of LED phototherapy on bone defects grafted with MTA, bone morphogenetic proteins and guided bone regeneration: a Raman spectroscopic study.
We studied peaks of calcium hydroxyapatite (CHA) and protein and lipid CH groups in defects grafted with mineral trioxide aggregate (MTA) treated or not with LED irradiation, bone morphogenetic proteins and guided bone regeneration. A total of 90 rats were divided into ten groups each of which was subdivided into three subgroups (evaluated at 15, 21 and 30 days after surgery). Defects were irradiated with LED light (wavelength 850 ± 10 nm) at 48-h intervals for 15 days. Raman readings were taken at the surface of the defects. There were no statistically significant differences in the CHA peaks among the nonirradiated defects at any of the experimental time-points. On the other hand, there were significant differences between the defects filled with blood clot and the irradiated defects at all time-points (p < 0.001, p = 0.02, p < 0.001). There were significant differences between the mean peak CHA in nonirradiated defects at all the experimental time-points (p < 0.01). The mean peak of the defects filled with blood clot was significantly different from that of the defects filled with MTA (p < 0.001). There were significant differences between the defects filled with blood clot and the irradiated defects (p < 0.001). The results of this study using Raman spectral analysis indicate that infrared LED light irradiation improves the deposition of CHA in healing bone grafted or not with MTA.
Center of Biophotonics, School of Dentistry, Federal University of Bahia, Av. Araújo Pinho, 62, Canela, Salvador, BA, CEP 40110-150, Brazil. albp@ufba.br
Antonio L B
AL
Pinheiro
Luiz G P
LG
Soares
Maria Cristina T
MC
Cangussú
Nicole R S
NR
Santos
Artur Felipe S
AF
Barbosa
Landulfo
L
Silveira Júnior
D017607:Aluminum Compounds / Q000008:administration & dosage; D000818:Animals; D019485:Bone Morphogenetic Proteins / Q000008:administration & dosage; D001861:Bone Regeneration / Q000187:drug effects / Q000528:radiation effects*; D018786:Bone Substitutes; D017610:Calcium Compounds / Q000008:administration & dosage; D004338:Drug Combinations; D017886:Durapatite / Q000378:metabolism; D048091:Guided Tissue Regeneration; D028022:Low-Level Light Therapy / Q000379:methods*; D008297:Male; D010087:Oxides / Q000008:administration & dosage; D051381:Rats; D017208:Rats, Wistar; D017640:Silicates / Q000008:administration & dosage; D013059:Spectrum Analysis, Raman
D017607:Aluminum Compounds; D019485:Bone Morphogenetic Proteins; D018786:Bone Substitutes; D017610:Calcium Compounds; D004338:Drug Combinations; D010087:Oxides; D017640:Silicates; C086631:mineral trioxide aggregate; D017886:Durapatite